NCT03500211

Post-Op Lidocaine Patch

Lidocaine Patch for Adjunct Analgesia for Postoperative Cesarean Birth Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Oregon Health and Science University · Academic / Other
• Sex: Female
• Age: 18 Years – 89 Years
• Healthy volunteers: Accepted

Summary

Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.

Detailed description

The purpose of this study is to determine if lidocaine patches decrease post-operative pain associated with cesarean births. While the Lidoderm lidocaine patch has been FDA approved for the treatment of skin pain, it has not been studied in women undergoing cesarean birth who experience postoperative pain. Even though this medication has been used in post-operative pain in published studies, the use of this medicine under these circumstances is still considered experimental. A lidocaine patch may provide added benefit for pain control in addition to standard medicines participants would receive after surgery, such as spinal, intravenous, and oral pain medications following cesarean delivery.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	Lidoderm 5 % Topical Patch	Lidocaine patch after cesarean section delivery.
OTHER	Sham Topical Patch	Sham patch after cesarean section delivery.

Timeline

• Start date: 2018-03-13
• Primary completion: 2019-03-01
• Completion: 2019-03-01
• First posted: 2018-04-18
• Last updated: 2020-03-11
• Results posted: 2020-03-11

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study